SteffelJVerhammePPotparaTS, et al.The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace2018; 20: 1231–1242.
2.
GibsonCMMehranRBodeC, et al.Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med2016; 375: 2423–2434.
3.
CannonCPBhattDLOldgrenJ, et al.Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med2017; 377: 1513–1524.
4.
KhanSUKhanMUGhaniAR, et al.Meta-analysis of antithrombotic therapy in atrial fibrillation after percutaneous coronary intervention. Am J Cardiol2018; 121: 1200–1206.
5.
LopesRDHeizerGAronsonR, et al.Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med2019; 380: 1509–1524.
6.
ValentineJCPigottTDRothsteinHR. How many studies do you need?: a primer on statistical power for meta-analysis. J Educ Behav Stats2010; 35: 215–247.
GolwalaHBCannonCPStegPG, et al.Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J2018; 39: 1726–1735a.
9.
CavallariIPattiG. Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol2018; 121: 718–724.
10.
LettinoMLeonardiSDe MariaE, et al.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease. Eur J Prev Cardiol2017; 24: 61–70.
11.
AngiolilloDJGoodmanSGBhattDL, et al.Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention. Circulation2018; 138: 527–536.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
